Eligibility for subcutaneous implantable cardioverter‐defibrillator in adults with congenital heart disease

AIMS: Patients with adult congenital heart disease (ACHD) carry an increased risk for sudden cardiac death. Implantable cardioverter‐defibrillator (ICD) therapy may be challenging in these patients due to anatomical barriers, repeated cardiac surgery, or complicated transvenous access. Thus, the sub...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:ESC Heart Fail
Main Authors: Zormpas, Christos, Silber‐Peest, Ann Sophie, Eiringhaus, Jörg, Hillmann, Henrike A.K., Hohmann, Stephan, Müller‐Leisse, Johanna, Westhoff‐Bleck, Mechthild, Veltmann, Christian, Duncker, David
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley and Sons Inc. 2021
Assuntos:
Original Research Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8006645/
https://ncbi.nlm.nih.gov/pubmed/33538124
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.13243
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares